polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.

Source:http://linkedlifedata.com/resource/pubmed/id/16002636

Download in:

View as

General Info

PMID
16002636